|
94
|
346
|
4iq6A |
Gsk-3beta with inhibitor 6-chloro-n-cyclohexyl-4-(1h-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine |
|
70
|
284
|
4i5mA |
Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein phosphorylation in rat brain |
|
100
|
338
|
4iirA |
Crystal structure of amppnp-bound human prpf4b kinase domain |
|
84
|
285
|
4i6bA |
Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein phosphorylation in rat brain |
|
106
|
337
|
4ib0A |
X-ray structure of camp dependent protein kinase a in complex with high na+ concentration, adp and phosphorylated peptide psp20 |
|
83
|
293
|
4j52A |
Crystal structure of plk1 in complex with a pyrimidodiazepinone inhibitor |
|
91
|
277
|
4i0sA |
Crystal structure of spleen tyrosine kinase complexed with 2-(6-chloro-1-methyl-1h-indazol-3-yl)-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid isopropylamide |
|
88
|
302
|
4ivcA |
Jak1 kinase (jh1 domain) in complex with the inhibitor (trans-4-{2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6h)-yl}cyclohexyl)acetonitrile |
|
193
|
660
|
4iwoA |
Crystal structure and mechanism of activation of tbk1 |
|
90
|
297
|
4k33A |
Crystal structure of fgf receptor 3 (fgfr3) kinase domain harboring the k650e mutation, a gain-of-function mutation responsible for thanatophoric dysplasia type ii and spermatocytic seminoma |
|
68
|
280
|
4jt3A |
Crystal structure of ttk kinase domain with an inhibitor: 400740 |
|
84
|
284
|
4i5pA |
Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein phosphorylation in rat brain |
|
152
|
464
|
4ifgA |
Crystal structure of tgcdpk1 with inhibitor bound |
|
208
|
659
|
4im0A |
Structure of tank-binding kinase 1 |
|
101
|
362
|
4jrnA |
Rop18 kinase domain in complex with amp-pnp and sucrose |
|
85
|
324
|
4jr3A |
Crystal structure of egfr kinase domain in complex with compound 3g |
|
75
|
285
|
4i6hA |
Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain |
|
45
|
205
|
4jmqA |
Crystal structure of pb9: the dit of bacteriophage t5. |
|
109
|
337
|
4ie9A |
Bovine pka c-alpha in complex with 3-pyridylmethyl-5-methyl-1h-pyrazole-3-carboxylate |
|
93
|
290
|
4jdjA |
Crystal structure of serine/threonine-protein kinase pak 4 f461v mutant in complex with paktide t peptide substrate |
|
110
|
337
|
4iazA |
Structure of camp dependent protein kinase a in complex with high ba2+ concentration, adp and phosphorylated peptide psp20 |
|
92
|
292
|
4ivaA |
Jak2 kinase (jh1 domain) in complex with the inhibitor trans-4-[(8as)-2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(8ah)-yl]cyclohexanecarbonitrile |
|
83
|
274
|
4k0yA |
Structure of pim-1 kinase bound to n-(4-fluorophenyl)-7-hydroxy-5-(piperidin-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
83
|
269
|
4hyhA |
X-ray crystal structure of compound 39 bound to human chk1 kinase domain |
|
161
|
464
|
4ihpA |
Crystal structure of tgcdpk1 with inhibitor bound |
|
76
|
265
|
4jaiA |
Crystal structure of aurora kinase a in complex with n-{4-[(6-oxo-5,6-dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide |
|
160
|
463
|
4jbvA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1268 |
|
83
|
285
|
4i6fA |
Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein phosphorylation in rat brain |
|
99
|
348
|
4j71A |
Crystal structure of gsk3b in complex with inhibitor 1r |
|
81
|
292
|
4joaA |
Crystal structure of human anaplastic lymphoma kinase in complex with 7-azaindole based inhibitor |
|
94
|
297
|
4i94A |
Structure of bsk8 in complex with amp-pnp |
|
100
|
337
|
4hptE |
Crystal structure of the catalytic subunit of camp-dependent protein kinase displaying complete phosphoryl transfer of amp-pnp onto a substrate peptide |
|
111
|
339
|
4hpuE |
Crystal structure of the catalytic subunit of camp-dependent protein kinase displaying partial phosphoryl transfer of amp-pnp onto a substrate peptide |
|
93
|
292
|
4hnfA |
Crystal structure of ck1d in complex with pf4800567 |
|
96
|
294
|
4hokA |
Crystal structure of apo ck1e |
|
97
|
302
|
4hglA |
Crystal structure of ck1g3 with compound 1 |
|
81
|
282
|
4hjoA |
Crystal structure of the inactive egfr tyrosine kinase domain with erlotinib |
|
89
|
263
|
4hcuA |
Crystal structure of itk in complext with compound 40 |
|
105
|
356
|
4h36A |
Crystal structure of jnk3 in complex with atf2 peptide |
|
100
|
302
|
4hgsA |
Crystal structure of ck1gs with compound 13 |
|
91
|
265
|
4hctA |
Crystal structure of itk in complex with compound 52 |
|
104
|
352
|
4h3qA |
Crystal structure of human erk2 complexed with a mapk docking peptide |
|
115
|
356
|
4h3bA |
Crystal structure of jnk3 in complex with sab peptide |
|
92
|
286
|
4hgtA |
Crystal structure of ck1d with compound 13 |
|
100
|
349
|
4h3pA |
Crystal structure of human erk2 complexed with a mapk docking peptide |
|
90
|
263
|
4hcvA |
Crystal structure of itk in complex with compound 53 |
|
105
|
356
|
4h39A |
Crystal structure of jnk3 in complex with jip1 peptide |
|
92
|
291
|
4hniA |
Crystal structure of ck1e in complex with pf4800567 |
|
92
|
290
|
4hgeA |
Jak2 kinase (jh1 domain) in complex with compound 8 |
|
72
|
275
|
4h58A |
Braf in complex with compound 3 |
